The development of red blood cells from hematopoietic progenitors requires the interplay of speci®c extracellular factors and transcriptional regulators. Here we have identi®ed an erythroid progenitor that is critically dependent on bFGF and requires expression of AMV v-Myb for sustained proliferation in vitro, indicating that bFGF and Myb proteins cooperate in these cells. In the presence of bFGF such v-Myb cells are completely blocked in their ability to dierentiate and exhibit an exceptionally high proliferative potential and long lifespan in vitro. Interestingly, in the absence of bFGF cells eectively dierentiate into mature erythrocytes, irrespective of constitutive and elevated levels of v-Myb. We also demonstrate that these cells express high levels of FGF receptor type 1 (FGFR1) and that phospholipase Cg (PLCg) is one of the important molecules in FGF receptor signaling. Our studies suggest that bFGF, in cooperation with Myb proteins, represents an important factor for determining erythroid lineage choice. These ®ndings unravel a so far unidenti®ed link between extracellular signaling and Myb in hematopoietic cells.
Introduction
Red blood cells represent one of the most abundant specialized cell types in vertebrate organisms. They develop from multipotent hematopoietic progenitor cells through successive steps of dierentiation, including a common myeloid progenitor (CMP) and progenitors that are already committed to the red cell lineage, like BFU-E and CFU-E (burst forming units erythroid and colony forming units erythroid), respectively (Orkin, 1996 (Orkin, , 2000 Akashi et al., 2000) . This development is tightly controlled by external and intrinsic factors to ensure both the maintenance of a progenitor cell pool in the bone marrow and the controlled release of mature red cells into peripheral blood to meet the needs of the organism.
The c-myb proto-oncogene is essential for the development of de®nitive erythroid and myeloid cells as documented by gene targeting experiments (Mucenski et al., 1991) . It is required for the expansion of immature erythroid, myeloid and lymphoid cells, and downregulated during their terminal dierentiation (Weston, 1998) . Two avian oncogenic retroviruses, avian myeloblastosis virus (AMV) and E26 virus, contain transduced c-myb sequences, referred to as AMV v-myb and E26 v-myb, respectively. AMV and E26 viruses cause acute myeloid and erythroid leukemia, respectively, and eectively transform chicken hematopoietic cells in vitro (Graf, 1992 (Graf, , 1998 Ganter and Lipsick, 1999) . AMV v-myb is thought to exclusively transform cells of the myelomonocytic lineage while E26 v-myb transforms erythroid and myeloid cells and multipotent progenitors.
Erythropoietin (Epo) and stem cell factor (SCF, kit ligand, KL) represent the most prominent factors that regulate erythropoiesis in vivo and in vitro (Krantz, 1991; Broudy, 1997) . Accordingly, targeted gene inactivation of Epo and Epo receptor demonstrated that Epo is indispensable for adult hematopoiesis (Wu et al., 1995) . Furthermore, genetic mutations of SCF and SCF receptor in Steel (SI) and Dominant white spotting (WW) loci, respectively, were associated with severe anemia (Broudy, 1997) . Other factors such as basic ®broblast growth factor (bFGF, FGF-2), transforming growth factor a (TGFa) and members of the TGFb family, including TGFb, bone morphogenic proteins (BMPs) and activin A, are also involved (Krystal et al., 1994; Dickson et al., 1995; Huber et al., 1998; Mead and Zon, 1998; Gandrillon et al., 1999; Koritschoner et al., 1999) .
bFGF is a member of a large gene family that comprises at least 23 FGFs (Klint and ClaessonWelsh, 1999; Schlessinger et al., 2000) . The biological activities of FGFs are mediated through binding to high anity FGF receptors (FGFRs) . FGFRs are receptor tyrosine kinases (RTKs) that utilize several signaling pathways involving various signal transduction proteins, such as Crk, Shc, phospholipase Cg (PLCg), FRS-2, Src and SHP-2 (Klint and Claesson-Welsh, 1999; Szebenyi and Fallon, 1999) . So far, cDNAs coding for four FGFRs have been identi®ed (FGFR1 ± 4). Various FGF members activate individual FGFRs to dierent extent depending on their binding anity and the cellular context. bFGF for example is involved in the proliferation and dierentiation of many cell types, including hematopoietic cells (Allouche, 1995) . In the hematopoietic compartment, bone marrow stroma cells express and produce bFGF that aects early and committed hematopoietic cells.
Here we report on an early erythroid progenitor from 2-day-old chicken embryo (blastoderm) that is critically dependent on bFGF and requires expression of v-Myb protein for sustained proliferation in vitro. This bFGF dependent progenitor exhibits an exceptionally high proliferative potential and long lifespan in culture of more than 50 population doublings, and dierentiates into fully mature erythrocytes after addition of dierentiation factors.
Results

bFGF causes growth of primitive erythroid cells containing v-Myb and c-Myb
Our previous work demonstrated that bFGF cooperates with various growth factors in the development of de®nitive erythroid progenitor cells (Koritschoner et al., 1999) . Additionally, bFGF alone was found to be ineective in supporting progenitor cell growth but caused sustained growth of immature progenitors derived from blastoderm that expressed elevated levels of v-Myb (Kara®at et al., 2001) .
Primitive and de®nitive hematopoietic cells were prepared from blastoderm of 2-day chicken embryos or bone marrow, respectively, and infected with v-Myb and c-Myb expressing retroviral vectors. Cells were then cultured with bFGF plus SCF or with bFGF alone, and cumulative cell numbers were determined in regular time intervals. In cultures of primitive blastoderm derived cells, an outgrowth of immature blastlike cells was observed at day 5 ± 7 with bFGF plus SCF and bFGF alone, and cells grew for more than 50 days ( Figure 1a and data not shown). In these cultures v-myb cells showed higher proliferation rates than cmyb cells. No outgrowth was observed in non-infected control cultures irrespective of the presence or absence of bFGF and SCF. Thus, it appears that proliferation of primitive blastoderm derived cells was critically dependent on the presence of bFGF and Myb expression. These cells will in the following be referred to as bFGF/v-myb and bFGF/c-myb progenitors.
In parallel experiments performed with infected bone marrow cells, an initial outgrowth of blast-like cells was also seen in the absence of myb infection ( Figure  1b ). This was not unexpected since under these conditions both myeloid and erythroid SCF dependent cells would transiently grow (P Bartunek, unpublished results; Dolznig et al., 1995) . However, from day 10 onwards only v-myb and c-myb containing cultures proliferated.
At day 18 of culture cells were subjected to cytochemical analysis. Blastoderm derived bFGF/vmyb cells exhibited an erythroid progenitor-like phenotype which was even more pronounced in bFGF/c-myb cells where partially and terminally dierentiated erythroid cells were observed. In bone marrow derived cultures v-myb cells clearly represented monoblast-like cells and c-myb cells also showed a myeloid phenotype. Additionally, c-myb cultures were more heterogeneous and contained mainly granulocytes that resembled promyelocytes (Figure 1c,d) .
The v-myb and c-myb cells of blastoderm and bone marrow were then characterized by antibodies speci®c for myeloid or erythroid surface antigens and¯ow cytometry, as well as for lineage speci®c markers including GATA-1 (erythroid), C/EBPb (NF-M; mye- loid/monocytic) and Mim-1 (granulocytic/promyelocytic). As expected from the cytochemical staining, blastoderm derived bFGF/v-myb and bFGF/c-myb cells expressed the erythroid speci®c surface antigen JS4 and no detectable levels of the myeloid antigens MC51-2 and MC47-3 (Figure 2a and data not shown). In addition cells expressed high levels of transferrin receptor detected by JS8 monoclonal antibody which is particularly high in erythroid progenitors. In contrast, bone marrow derived v-myb and c-myb cells expressed the myeloid antigens MC51-2 and MC47-3 and no JS4 antigen. These cells also expressed moderate levels of transferrin receptor which is routinely observed in highly dividing cells and is augmented by transferrin present in culture medium (Figure 2a and data not shown).
To further extend these studies, cells were analysed by Western blotting for expression of lineage speci®c markers. Blastoderm derived bFGF/v-myb and bFGF/ c-myb cells expressed high levels of the erythroid marker GATA-1 while the myeloid marker C/EBPb was absent. In bone marrow derived cells however, C/ EBPb was highly expressed and GATA-1 was undetectable. Interestingly, bone marrow derived cmyb cells contained high levels of the promyelocytic Mim-1 protein. Mim-1 protein expression steadily increased and at later stages of culture reached levels that were readily detectable by gel electrophoresis and Coomassie blue staining (Figure 2b and data not shown). Finally, cells were analysed for globin expression by Northern blotting and found to express only embryonic r-globin but not adult b-globin (data not shown).
In conclusion, bFGF together with v-Myb or c-Myb induced self-renewal of primitive erythroid progenitors from early chick embryos while with bone marrow cells an outgrowth of myeloid cells was observed.
bFGF and v-Myb cooperate to induce self-renewal and extended lifespan of erythroid progenitors
The proliferative potential and lifespan of bFGF/v-myb cells were analysed in long-term suspension cultures and in colony assays. Cells in suspension cultures reached 50 (and even more) population doublings corresponding to 10 18 cells (Figure 3a and data not shown). This lifespan dramatically exceeds that of normal chicken erythroid progenitors (Dolznig et al., 1995; Beug et al., 1996) . Another striking feature of these cells is their high doubling rate of 17 h per division as compared to 22 ± 24 h for normal erythroid progenitors (Dolznig et al., 1995; Steinlein et al., 1995) . Furthermore, cells displayed a high clonogenic potential in the presence of bFGF and representative colonies in semi-solid methylcellulose medium are depicted in Figure 3d . Individual clones could be further propagated in liquid culture with bFGF (data not shown and Kara®at et al., 2001) .
In the course of dierent experiments, bFGF/v-myb cells at early time points of culture exhibited also the myeloid surface antigen detected by MC51-2 antibody ( Figure 3e , day 12; and data not shown). The proportion of MC51-2 positive cells gradually decreased with time when the culture became more homogenous. By day 18 of culture no MC51-2 speci®c signal was observed and only erythroid speci®c markers were present (Figures 2a and 3e and data not shown).
Finally, the eect of dierent growth factors (bFGF, SCF and TGFa) on the phenotype of bFGF efficiently blocks erythroid differentiation and promotes proliferation of bFGF/v-myb cells
Next we assessed the ability of bFGF/v-myb cells to undergo terminal dierentiation into erythrocytes. Cells were induced to dierentiate by anemic serum (as a source of erythropoietin) and insulin, and evaluated by cell morphology, cell size and hemoglobin content. Surprisingly, v-Myb did not block terminal dierentiation despite elevated v-Myb protein levels in these cells (Figures 2b and 4a,b) and cells dierentiated into fully mature erythrocytes after 3 ± 4 days. Without factors cells showed a propensity to dierentiate but stopped dividing and eventually died, while control cells grown with bFGF remained immature and retained their potent growth characteristics. Since growth and survival of bFGF/v-myb cells is strictly dependent on bFGF, we investigated the in¯uence of bFGF on terminal dierentiation. Remarkably, bFGF/v-myb cells induced to dierentiate in the presence of bFGF were completely blocked in their ability to undergo dierentiation and kept their selfrenewing property and immature phenotype ( Figure  4a ). This result was further supported by measuring other dierentiation parameters including cumulative cell numbers, cell volume and hemoglobin content (Figure 4b ). Following dierentiation induction in the absence of bFGF there was an initial phase characterized by a higher rate of proliferation ( Figure 4b ) and then cells stopped dividing after 3 to 4 days (Dolznig et al., 1995) . Concomitantly cells reduce their volume and accumulate hemoglobin (Figure 4b ). In the presence of bFGF however, bFGF/v-myb cells continued to proliferate at a high rate (Figure 4b and data not shown), retained the volume of immature cells of approximately 500¯and did not accumulate hemoglobin.
Multiple FGF receptors are expressed in bFGF/v-myb cells
To identify the FGFR member(s) that is/are expressed in bFGF/v-myb and bFGF/c-myb cells and thus are responsible for the bFGF eects, Northern blotting was employed. FGFR1 ± 4 cDNA fragments were used as hybridization probes. bFGF/v-myb cells expressed high levels of FGFR1 ( Figure 5 ) which were similar to positive controls (brain and chicken embryo ®bro-blasts, CEF). FGFR1 was also abundantly expressed in the erythroid cell line HD3 while it was very low to undetectable in bone marrow derived erythroid progenitors. No FGFR1 expression was found in myeloid cells. bFGF/v-myb cells expressed also moderate levels of FGFR3 and very low levels of FGFR2 and FGFR4. Since FGFR1 was not detected in bFGF/ c-myb cells, more sensitive RT ± PCR analysis was employed. FGFR1 expression was barely detectable in these cells (data not shown) which is in marked contrast to its abundant expression in bFGF/v-myb cells. Thus we conclude that FGFR1 appears to be the major FGF receptor that is responsible for bFGFdependent signaling in bFGF/v-myb cells. To gain further insights into the signaling pathways emanating from the FGFRs expressed in bFGF/v-myb cells, two representative members of the FGF family, aFGF (acidic FGF, FGF-1) and bFGF were compared in cell proliferation assays. As shown in Figure 6a , nanogram concentrations of bFGF induced a maximal stimulation, whereas 100 times higher levels of aFGF stimulated bFGF/v-myb cell proliferation only marginally if at all. Surprisingly, the overall tyrosine phosphorylation pattern induced by aFGF and bFGF were very similar (Figure 6b ) with the exception of a 90 kDa protein that became apparent after 120 min of exposure only to bFGF and thus correlated with speci®c mitogenic signal elicited via bFGF. A protein of similar size was found in PLCg immunoprecipitates and speci®cally phosphorylated by bFGF but not by aFGF as revealed by Western blotting with phosphotyrosine speci®c antibody (data not shown). This protein was however not PLCg as judged by Western blot analysis with PLCg speci®c antibody, and its identity still remains elusive. Thus, aFGF seems to eectively bind to cognate receptor and to induce phosphorylation of certain substrates but failed to activate a proliferative response. Reprobing of phosphotyrosine blots with anti-SHC antibody indicated that the major 55 kDa phosphoprotein induced by aFGF and bFGF is the adaptor molecule SHC (Figure 6b ; and data not shown). Immunoprecipitation of SHC proteins from lysates of induced and non-induced cells, followed by Western blot analysis with anti-phosphotyrosine antibody, detected phosphorylated SHC only in immunoprecipitates of aFGF and bFGF treated cells but not in untreated control or in insulin treated cells ( Figure 6c ). As an additional control the b subunit of insulin receptor was immunoprecipitated and reacted with anti-phosphotyrosine antibody to reveal the speci®c phosphorylation of the b subunit of insulin receptor (Figure 6c , lower panel). Other known FGFR substrates including CRK and FRS2/SNT were not phosphorylated under these conditions (data not shown). Thus, SHC phosphorylation was eectively induced by both aFGF and bFGF.
The lack of a mitogenic response to aFGF led us to explore the eect of heparin that is known to enhance high anity binding of FGF ligands to cognate receptors and to augment the mitogenic potential of aFGF. There was no further increase in the bFGF proliferative response by heparin while a clear enhancement of the mitogenic signal was induced by aFGF. However, even 10 times higher concentrations of aFGF plus heparin were still an order of magnitude less eective in stimulating bFGF/v-myb cell proliferation than bFGF alone (Figure 7a ). This suggests that bFGF most likely represents the natural ligand or at least a prototype of FGF factors that are active on bFGF/v-myb cells.
PLCg signaling pathway is involved in the mitogenic signal induced by bFGF
The phosphorylation status of downstream signaling substrates of ligand activated FGFRs provided only limited information on the pathways involved in the mitogenic response to bFGF. Therefore, speci®c inhibitors of signaling molecules aecting various pathways were employed. Neither Ras inhibitor FTS (inhibitor of farnesylation) nor src family inhibitor PP-2 had any eect on bFGF induced bFGF/v-myb cell proliferation even at concentrations 10 times higher than routinely eective (Figure 7b and data not shown). The phosphatidylinositol 3-kinase (PI3-kinase) inhibitor Wortmannin was also ineective while the MEK inhibitor PD 98059 was partially inhibitory only at higher concentrations (Figure 7b and data not shown). Importantly, the PLCg It has been shown that PLCg signaling leads to activation of protein kinase C (PKC) via diacylglycerol (DAG) and increases intracellular calcium by inositol triphosphate (Ins3P). Increased calcium has pleiotropic eects and can result in activation of calmodulin dependent protein kinase (CaMKII) and calcineurin (phosphatase PP2B). Therefore inhibitors of calcium dependent pathways were also tested. The PKC inhibitor GF109203X reduced bFGF induced bFGF/ v-myb cell proliferation by 30%, while the reduction by the calcineurin inhibitors cyclosporine A and cypermethrin was 45% (Figure 7b and data not shown). Sixty per cent of inhibition was measured in the presence of KN-62, a speci®c inhibitor of CaMKII. Taken together these data suggest that in bFGF/v-myb progenitors PLCg might be one of the important molecules that triggers mitogenic signaling emanating from bFGF while further downstream signaling events involve multiple transduction pathways.
Discussion
The c-Myb protein is one of the key regulators of hematopoietic cell development and its expression is particularly high in erythroid progenitor cells (Ness, 1996; Sieweke and Graf, 1998; Ganter and Lipsick, 1999) . Erythropoiesis depends on the intricate interplay of signaling pathways, that are activated by external stimuli, with transcription factors such as Myb which directly regulate gene expression (Ness and Engel, 1994; Cross and Enver, 1997; Sieweke and Graf, 1998; Orkin, 2000) . Here we describe an immature erythroid progenitor derived from 2-day-old chicken embryo (blastoderm) that is critically dependent on bFGF signaling and Myb for proliferation and survival in vitro. These bFGF/v-myb cells exhibit an extraordinarily high proliferative potential of more than 50 population doublings corresponding to an ampli®ca-tion of more than 10 15 . Additionally, bFGF/v-myb cells represent fully functional erythroid precursors since they eectively dierentiate in response to dierentiation factors (erythropoietin and insulin) into hemoglobinized erythrocytes within 3 ± 4 days. bFGF is abundantly expressed in blood islands of 2 days old chicken embryos where primitive erythroid cells develop (P Bartunek and M Zenke, unpublished) and is also produced by stroma cells in adult bone marrow (Brunner et al., 1993; Gordon-Thomson and Fabian, 1994; Allouche, 1995) . Although present at sites of erythropoiesis, bFGF is not considered a hematopoietic growth factor per se. bFGF was however reported to be important for proliferation of hemangioblast, a common progenitor of endothelial and hematopoietic cells (Faloon et al., 2000) . Additionally, bFGF was found in our previous studies to synergize with other growth factors in inducing proliferation of primitive uncommitted progenitors and de®nitive erythroid cells (Koritschoner et al., 1999) . We demonstrate here that bFGF is a key factor for proliferation and survival of primitive erythroid progenitors and thus in fact represents a hematopoietic growth factor. Importantly, its hematopoietic potential manifests itself only in conjunction with high levels of v-Myb transcription factor. This ®nding unravels a so far unidenti®ed link between extracellular signals and Myb in hematopoietic cells. Interestingly, a similar cooperation of bFGF and Myb proteins was observed before for chicken neuroretina cells (Garrido et al., 1992; Turque et al., 1997) . As a ®rst step towards elucidating the bFGF-Myb pathway, FGF receptor expression in bFGF/myb cells and the signaling pathways involved were analysed. bFGF/v-myb progenitors express all known FGFRs (FGFR1 ± 4) and eectively respond to bFGF. Interestingly, FGFR1, was particularly high in bFGF/v-myb erythroid progenitors but not in the respective myeloid cells. This observation might well explain the potent mitogenic response to bFGF observed for bFGF/vmyb erythroid cells and sheds light into the cooperative action of bFGF and Myb proteins in these cells. It is therefore tempting to speculate that v-Myb regulates, by a direct or indirect mechanism, FGFR1 expression in erythroid progenitor cells. The presence of potential Myb binding sites in the human FGFR1 promoter (accession no. L0051033) might suggest a direct mechanism of FGFR1 activation by Myb proteins. An immortalized cell line, representing primitive erythroid cells derived from mouse embryoid bodies, was found to express FGFR1, and bFGF was a mitogenic factor for these cells (Yuen et al., 1998) .
Interestingly, aFGF, another member of the FGF family, is not a potent mitogenic factor for bFGF/vmyb cells and was found to be at least 10 ± 100-fold less eective (even in the presence of heparin) than bFGF. Yet both aFGF and bFGF induced a similar pattern of phosphorylated proteins including the SHC adapter molecule. A more detailed analysis of the signaling molecules involved in bFGF/v-myb progenitor growth identi®ed PLCg as an important component in mitogenic signaling of these cells. Further downstream, multiple signaling pathways appeared to be activated by bFGF, including the kinases PKC and CaMKII, and phosphatase PP2B (calcineurin), as revealed by speci®c inhibitors (for a model see Figure 8a ). These signaling pathways might eventually converge on the Myb protein and modulate its activity via phosphorylation or dephosphorylation. Preliminary experiments did indeed reveal a determining role of v-Myb phosphorylation status on the ability of Myb to support development of erythroid cells in vitro (P Bartunek and M Dvorak, unpublished) .
The c-Myb protein is highly expressed in erythroid progenitors (Ness, 1996; Sieweke and Graf, 1998; Ganter and Lipsick, 1999) and eectively downregulated when cells cease proliferation and dierentiate (Zenke et al., 1990; Disela et al., 1991; Dolznig et al., 1995; Bartunek and Zenke, 1998) . Downregulation of c-myb is believed to be a prerequisite for terminal dierentiation of erythroid cells and constitutive expression of c-Myb in mouse erythroleukemia cell lines eectively blocked dierentiation (Cuddihy et al., 1993; Lyon and Watson, 1995) . However, in the primary erythroid cells studied in this paper even elevated v-Myb (and c-Myb) levels, that were much higher than endogenous c-Myb, did not prevent terminal dierentiation. Although v-Myb protein expression declined during bFGF/v-myb cell dierentiation to some extent, v-Myb levels were similar to cMyb expression in proliferating bFGF/c-myb cells that ectopically express elevated c-Myb (data not shown). Thus, in bFGF/v-myb cells elevated v-Myb expression still allowed erythroid dierentiation which might indicate that the v-Myb protein is functionally inactivated by e.g. post-translational modi®cation. Immortalized cell lines frequently have aberrant properties (such as constitutively active kinase signaling) and this might well explain the apparent discrepancy between the results reported here and those obtained with cell lines. Thus information about mechanisms, that drive hematopoietic cell development in vivo, can be obtained reliably only from primary cells.
There are however dierences between bFGF/c-myb and bFGF/v-myb progenitors which might be related to dierent expression levels of Myb proteins or rather re¯ect dierences in intrinsic properties of both proteins.
(1) FGFR1 expression in bFGF/v-myb progenitors was much higher than in bFGF/c-myb cells (P Bartunek, P Pajer, M Dvorak and M Zenke, unpublished) and consequently bFGF/v-myb cells were found to respond more eectively to bFGF and also showed higher proliferation rates. (2) bFGF/v-myb progenitors were completely blocked in dierentiation by bFGF even in the presence of dierentiation factors. In contrast, bFGF/c-myb progenitors underwent terminal dierentiation in response to dierentiation factors both in the absence and presence of bFGF with similar eciency and kinetics (P Bartunek, M Dvorak and M Zenke, unpublished) .
Finally, this study suggests that bFGF directs commitment of an early v-Myb progenitor to the erythroid lineage while in the absence of bFGF, v-Myb progenitor develops into monoblasts. Thus, the cooperation of bFGF and v-Myb activity appears to be the critical determinant in directing development of this common progenitor to the erythroid lineage (for a model see Figure 8b ). Additionally, the erythroid bFGF/v-myb cells exhibit an exceptionally high proliferative potential and long lifespan in vitro and in the absence of bFGF cells eectively dierentiate into mature erythrocytes, irrespective of constitutive and elevated levels of v-Myb.
Materials and methods
Cells and cell culture
Chicken embryo ®broblasts (CEF) were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 8% fetal calf serum (FCS; Sebak, Switzerland) and 2% chicken serum (ChS; Sigma), 20 mM HEPES pH 7.3 and 100 units/ml Penicillin/Streptomycin (Gibco-BRL). Retroviral vector DNA (10 mg) pNeoAMV and pNeoCCC (Lipsick et al., 1986) containing v-myb and c-myb, respectively, were transfected into CEF (together with 1 mg MAV-1 helper virus DNA, pATMAV-1; Pecenka et al., 1988) and neoresistant virus producing cells were selected (800 mg/ml G418; Gibco-BRL). Blastoderm derived cells (day 2 of incubation, Hamburger ± Hamilton stage HH 10 ± 12) and bone marrow cells (day 4 ± 7 old chicks) were cocultivated for 2 days with mitomycin C treated virus producing or control (uninfected) CEF in CFU-E medium containing bFGF (25 ng/ml, Promega), chicken SCF (100 ng/ml; , TGFa (5 ng/ml; Promega) or dierent combinations thereof, or no factors. After 2 days nonadherent cells were recovered and cells were grown at 2610 6 cells/ml. An outgrowth of myb transformed cells was routinely observed at day 5 ± 7 and cell numbers were determined in regular time intervals using the Cell Counter and Analyser System using the CASY-1 Cell Counter and Analyser System (SchaÈ rfe System, Reutlingen, Germany).
For analysis of cell morphology, cells were cytocentrifuged onto glass slides (700 r.p.m., 7 min, Cytospin 2, Shandon Inc., Pittsburgh, USA), ®xed in methanol and stained with Di-Quik (Baxter, Switzerland). Cell preparations were rinsed with water and mounted with Entellan (Merck). Photographs were taken with Axiophot II microscope (Zeiss) and Kontron ProgRes 3012 CCD camera (Kontron, Munich, Germany) and processed using Adobe Photoshop software.
Colony assay
Two days after infection 5610 5 cells were seeded in semisolid methocel medium containing 0.8% methylcellulose in CFU-E medium supplemented with 25 ng/ml of bFGF.
Proliferation assays
Cell proliferation was measured as rate of DNA synthesis by 3 H-thymidine incorporation or using CellTiter96 1 (Promega). Brie¯y, cells (4610 4 cells/100 ml) were incubated in CFU-E medium with 0.8 mCi 3 H-thymidine (speci®c activity 29 Ci/mmol; Amersham, UK) for 2 h at 378C, harvested onto ®lter plates and subjected to scintillation counting. Average values from triplicate samples were determined. CellTiter96 1 MTS assay was for 2 h. Heparin (B Braun, Melsungen, Germany) was used at 5 mg/ml. Inhibitors were used at the following concentrations PD98059 (5 mM), PP2 (100 nM), U-73122 (1 mM), Wortmannin (100 nM), Cyclosporin A (10 nM), GF 109203X (10 nM), and KN-62 (1 mM); (all from Calbiochem).
Differentiation assay
To induce erythroid dierentiation, cells were incubated in CFU-E medium without ChS (2610 6 cells/ml) supplemented with 3% anemic chicken serum (as a source for erythropoietin) plus 10 ng/ml recombinant human insulin (Novo Nordisk) in the presence or absence of 25 ng/ml bFGF. Erythroid dierentiation was assessed by (1) determining hemoglobin accumulation in cytospin preparations stained with neutral benzidine and Di-Quik (Baxter, Switzerland), or in hemoglobin assay ; (2) measuring reduction in cell size with the CASY-1 Cell Counter and Analyzer System; and (3) loss of proliferative potential in 3 Hthymidine incorporation assays. Photographs were taken by 5 and processed as above.
Flow cytometry
Surface antigen expression was analysed by¯ow cytometry. 10 6 cells were recovered, washed in PBS containing 1% bovine serum albumin (BSA, Fraction V, Sigma) and incubated with speci®c monoclonal antibodies (1 h), followed by reaction with FITC-conjugated anti-mouse IgG (Fc speci®c; 45 min; Jackson Laboratories). The following antibodies were used: MC51-2, MC47-83 (Kornfeld et al., 1983) ; JS4, JS8 (Schmidt et al., 1986) . Cells were washed twice and resuspended in PBS containing 1% BSA and propidium iodide (2 mg/ml; Sigma). For¯ow cytometric analysis Calibur 1 FACScan device with CellQuest Software (Becton Dickinson) were used.
RNA preparation and Northern blot analysis
Total RNA was prepared and analysed by Northern blotting (Bartunek and Zenke, 1998) . Blots were stained with Methylene Blue to demonstrate equal RNA loading per lane. Probes correspond to cDNA of chicken FGFR1, FGFR2, FGFR3 (Cek1, Cek3 and Cek2, respectively; Pasquale, 1990) and chicken FGFR4 (Koritschoner et al., 1999) .
Western blot analysis and immunoprecipitation
For analysis of tyrosine phosphorylation in response to factor, cells were deprived from growth factors (16 h) in CFU-E medium and stimulated for various periods of time with 250 ng/ml aFGF or bFGF, or 1 mg/ml insulin. Cells were lysed in lysis buer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 1% Triton X-100, 1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mM PMSF, 1 mM sodium orthovanadate) and used for immunoprecipitation or Western blot analysis. For immunoprecipitation lysates were precleared with anti-rabbit IgG agarose (Sigma) and incubated with the rabbit polyclonal antibodies against SHC, Crk and insulin receptor b chain (Transduction Laboratories). Immunocomplexes were precipitated with anti-rabbit IgG agarose and washed with lysis buer (three times) and with 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA. For detection of FRS2/SNT p13-suc1 protein conjugated to agarose (Calbiochem) was used accordingly.
For Western blot analysis, protein lysates (or immunoprecipitates) were separated on 10% or 12% SDS ± PAGE gels and blotted onto nitrocellulose membranes (Schleicher and Schuell, BA85). For anti-phosphotyrosine (4G10; Upstate Biotechnology, Inc., NY, USA) and anti-bFGF (Transduction Laboratories, KY, USA) monoclonal antibodies, membranes were blocked overnight in TBS (25 mM Tris-HCl pH 7.4, 137 mM NaCl, 5 mM KCl, 0.7 mM CaCl 2 , 0.5 mM MgCl 2 , 0.6 mM Na 2 HPO 4 ) containing 3% BSA, 1 mM EDTA, 0.05% Tween-20 at room temperature, washed twice with wash buer (50 mM Tris-HCl pH 8.0, 0.1 M NaCl, 0.1% Tween-20) and incubated with ®rst antibody in wash buer (1 h). For polyclonal antibodies against Myb (Bartunek et al., 1997) , GATA-1 (Briegel et al., 1996) , C/EBPb (Mink et al., 1996) , Mim-1 (Ness et al., 1989) , and monoclonal anti-SHC and anti-InsRb antibodies (both Transduction Laboratories, KY, USA), membranes were blocked overnight in 5% non-fat milk powder in TBS or PBS containing 0.05% Tween-20 and incubated with antibody in blocking solution. Subsequently, blots were washed ®ve times with wash buer and incubated with secondary antibody (ECL kit, Amersham) in TBS supplemented with 5% non-fat milk for 45 min at room temperature. The membranes were washed ®ve times with wash buer, developed in ECL reagents (Amersham) and exposed to ®lm.
